Malvern PA – September 24, 2018. A new cell based profiling service for drug discovery announced by Reaction Biology Corporation (RBC), a premier provider of drug discovery services, and Promega Corporation, a worldwide leader in the supply of life science products, will allow more researchers to better prioritize compounds earlier. Based on Promega NanoBRETTM technology,... Read more
Basel, 24 September 2018 Roche announces global availability of blood-based genomic profiling test, FoundationOne Liquid Liquid biopsy test can identify 70 of the most commonly mutated genes in solid tumours, as well as microsatellite instability Many cancer patients have insufficient or inadequate tissue for genomic testing and so may benefit from FoundationOne Liquid FoundationOne Liquid... Read more
Basel, 21 September 2018 CHMP recommends EU approval for subcutaneous formulation of RoActemra for use in active systemic juvenile idiopathic arthritis (sJIA), a rare form of juvenile arthritis Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the European Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for the subcutaneous... Read more
Basel, 21 September 2018 Roche announces CHMP recommendation for EU approval of Venclyxto plus MabThera for people with previously treated chronic lymphocytic leukaemia Positive CHMP recommendation based on randomised phase III MURANO study showing that fixed duration of treatment with Venclyxto plus MabThera is well tolerated and reduced risk of disease progression or death by... Read more
Supporting scientists through the collaborative development of next generation chromatography and mass spectrometry solutions in Pharma/Biopharma and Food/Beverage Industries WALTHAM, Mass., Sept. 20, 2018 /PRNewswire/ — Thermo Fisher Scientific Inc., the world leader in serving science, today announced its intent to open multiple Global Customer Solution Centers. The new Global Customer Solution Centers will focus... Read more
Burlington, Massachusetts, September 18, 2018 – MilliporeSigma today announced the opening of a new 3,800-square-meter laboratory in Singapore. 18 SEP 2018 | BURLINGTON, MASSACHUSETTS, UNITED STATES OF AMERICA First GMP BioReliance® biosafety testing lab in Asia Pacific offering critical testing services to bring life-changing therapies to market Extensive range of upstream and downstream bioprocessing solutions through M Lab™... Read more
Basel, 18 September 2018 Reminder: Invitation to Roche’s Virtual Pipeline Event: Key data for Roche’s lung cancer portfolio to be presented at the 2018 IASLC World Conference on Lung Cancer Agenda Roche lung cancer portfolio key data IMpower133: Primary PFS, OS, and Safety in a Ph1/3 Study of 1L Atezolizumab + Carboplatin + Etoposide in... Read more
NEW YORK; Sept. 17, 2018 – Accenture and Merck, known as MSD outside the United States and Canada, in collaboration with Amazon Web Services (AWS), will launch a cloud-based informatics research platform designed to help organizations in the life sciences industry improve productivity, efficiency and innovation in the early stages of drug development. The new research platform,... Read more
Thermo Scientific VetDrugs Explorer Collection provides LC-MS/MS-based solution for multi-class veterinary drug residues in sample matrices SAN JOSE, Calif., Sept. 17, 2018 /PRNewswire/ — Food scientists can now take advantage of a newly-launched, start-to-finish solution that offers robust, reliable and sensitive analysis of multi-residue veterinary drugs in complex animal-derived sample matrices, helping identify animal and dairy... Read more
Location: Cambridge, UK 14/09/2018 AstraZeneca joins Horizon’s Genomics Discovery Initiative CRISPR knockout and activation libraries are a key toolset in early research crRNA libraries are an efficient and convenient platform for gain- and loss-of-function studies Cambridge, UK, 14 September 2018: Horizon Discovery Group plc (LSE: HZD) (“Horizon” or “the Company”), a global leader in gene... Read more